These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 373665)

  • 1. Treatment of secondary depression in schizophrenia. A double-blind, placebo-controlled trial of amitriptyline added to perphenazine.
    Prusoff BA; Williams DH; Weissman MM; Astrachan BM
    Arch Gen Psychiatry; 1979 May; 36(5):569-75. PubMed ID: 373665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A controlled clinical trial of amitriptyline added to perphenazine in the treatment of depressed schizophrenics [proceedings].
    Prusoff BA; Williams DH; Weissman MM; Astrachan BM
    Psychopharmacol Bull; 1979 Apr; 15(2):80-1. PubMed ID: 373008
    [No Abstract]   [Full Text] [Related]  

  • 3. Amitriptyline-perphenazine interaction in ambulatory schizophrenic patients. A controled study of drug interaction.
    Chouinard G; Annable L; Serrano M; Albert JM; Charette R
    Arch Gen Psychiatry; 1975 Oct; 32(10):1295-307. PubMed ID: 1101843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacological treatment of delusional depression.
    Spiker DG; Weiss JC; Dealy RS; Griffin SJ; Hanin I; Neil JF; Perel JM; Rossi AJ; Soloff PH
    Am J Psychiatry; 1985 Apr; 142(4):430-6. PubMed ID: 3883815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind trial of amitriptyline/perphenazine, perphenazine and placebo in chronic withdrawn inert schizophrenics.
    Collins AD; Dundas J
    Br J Psychiatry; 1967 Dec; 113(505):1425-9. PubMed ID: 4865295
    [No Abstract]   [Full Text] [Related]  

  • 6. Antidepressants in 'depressed' schizophrenic inpatients. A controlled trial.
    Kramer MS; Vogel WH; DiJohnson C; Dewey DA; Sheves P; Cavicchia S; Little P; Schmidt R; Kimes I
    Arch Gen Psychiatry; 1989 Oct; 46(10):922-8. PubMed ID: 2679483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amoxapine versus amitriptyline combined with perphenazine in the treatment of psychotic depression.
    Anton RF; Burch EA
    Am J Psychiatry; 1990 Sep; 147(9):1203-8. PubMed ID: 2201223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A controlled outpatient trial of perphenazine--amitriptyline and chlorpromazine.
    Haskell DS; McNair DM; Fisher S; Kahn RJ
    J Clin Pharmacol; 1974 Oct; 14(10):536-42. PubMed ID: 4610016
    [No Abstract]   [Full Text] [Related]  

  • 9. Amitriptyline-perphenazine and doxepin in depressed outpatients: a controlled double-blind study.
    Rickels K; Csanalosi I; Werblowsky J; Weise CC; Weinstock R; Brown AS; Winokur A; Von Poelnitz M
    J Clin Psychiatry; 1982 Oct; 43(10):419-22. PubMed ID: 6749826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of second-generation antipsychotics and perphenazine on depressive symptoms in a randomized trial of treatment for chronic schizophrenia.
    Addington DE; Mohamed S; Rosenheck RA; Davis SM; Stroup TS; McEvoy JP; Swartz MS; Lieberman JA
    J Clin Psychiatry; 2011 Jan; 72(1):75-80. PubMed ID: 20868641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of a protriptyline-perphenazine combination in chronic psychiatric patients.
    St-Jean A; Ban TA; Scott J
    Curr Ther Res Clin Exp; 1966 Oct; 8(10):483-6. PubMed ID: 4961168
    [No Abstract]   [Full Text] [Related]  

  • 12. Amitriptyline and perphenazine in depressive illness. A controlled trial.
    Haider I
    Br J Psychiatry; 1967 Feb; 113(495):195-9. PubMed ID: 5340301
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapy for psychotic and psychoneurotic depression with thiothixene and perphenazine-amitriptyline (a double-blind clinical study).
    McLaughlin BE
    Dis Nerv Syst; 1969 Feb; 30(2):Suppl:85-8. PubMed ID: 4886995
    [No Abstract]   [Full Text] [Related]  

  • 14. Sulpiride and perphenazine in schizophrenia. A double-blind clinical trial.
    Lepola U; Koskinen T; Rimón R; Salo H; Gordin A
    Acta Psychiatr Scand; 1989 Jul; 80(1):92-6. PubMed ID: 2669445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating psychical disturbances induced by physical disorders: a double-blind study of perphenazine-amitriptyline in anxiety and depression.
    Davis WG
    Psychosomatics; 1968; 9(1):44-6. PubMed ID: 4867598
    [No Abstract]   [Full Text] [Related]  

  • 16. A placebo-controlled, double-blind trial of amitriptyline in bulimia.
    Mitchell JE; Groat R
    J Clin Psychopharmacol; 1984 Aug; 4(4):186-93. PubMed ID: 6381556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacologic combinations in the therapy of depression: experiences with Mutabon (perphenazine and amitriptyline)].
    Invernizzi G; Sostero M; Vitali A; Campanella F
    Riv Sper Freniatr Med Leg Alien Ment; 1971 Dec; 95(6):1143-81. PubMed ID: 5143725
    [No Abstract]   [Full Text] [Related]  

  • 18. A controlled trial of combined medications on behavioral and extrapyramidal effects.
    Simpson GM; Krakov L; Kunz-Bartholini E
    Acta Psychiatr Scand Suppl; 1970; 212():20-7. PubMed ID: 4917968
    [No Abstract]   [Full Text] [Related]  

  • 19. The pharmacological treatment of delusional depression: Part II.
    Spiker DG; Perel JM; Hanin I; Dealy RS; Griffin SJ; Soloff PH; Weiss JC
    J Clin Psychopharmacol; 1986 Dec; 6(6):339-42. PubMed ID: 3805326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxepin and amitriptyline-perphenazine in mixed anxious-depressed neurotic outpatients: a collaborative controlled study.
    Rickels K; Hutchison JC; Weise CC; Csanalosi I; Chung HR; Case WG
    Psychopharmacologia; 1972; 23(4):305-18. PubMed ID: 4554486
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.